{"nct_id":"NCT03652064","title":"A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2018-11-06","start_date_type":"ACTUAL","primary_completion_date":"2024-05-07","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-09","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}